Archives for May 31, 2019

Uber’s first post-IPO earnings report shows another $1 billion lost

by

The company’s operating losses have more than doubled year over year.

Uber’s first earnings report as a public company shows that while its revenue is higher than last year; the company is still hemorrhaging money. Still, there’s no doubt that the company is getting bigger. The company earned $3.1 billion in revenue for the first quarter of 2019, a 20 percent increase from the same period last year. But its losses were considerable; the company reported a net loss of $1.1 billion.

Uber Eats showed substantial growth in 2019, generating over $536 million in the first quarter and an 89 percent jump year-over-year. The growing popularity of Uber Eats is a mixed blessing for the company, which ends up paying restaurants and drivers more than it earns from users. As for Uber’s ridesharing business, growth was more modest. Adjusted net revenue for rideshare grew 10 percent from this time last year.

The rideshare company saw growth in all regions of the world except for Latin America, where it took a 13 percent hit in revenue from last quarter. Uber is in nine countries in the region, including Brazil, Peru, Mexico, Colombia, and Costa Rica. The company is facing fierce competition from Chinese-owned Didi in Mexico and locally-owned 99Taxis in Brazil, as well as a number of other regional apps.

Amazon is reportedly interested in buying Boost Mobile

by

If helping to create a competitor is a necessary condition to get the Sprint/T-Mobile deal done, then perhaps Amazon can help. A report from Reuters suggests the retailer is interested in buying Boost Mobile from the combo, particularly because it would come with the ability to use T-Mobile’s network for six years. The unnamed sources also claimed the company could be interested in spectrum the newly-merged pair would have to divest.

Amazon has tried to get into the mobile business before — remember the Fire Phone? — and it wouldn’t be a huge surprise to see it add wireless to the suite of services it offers. Yesterday’s report pointed to the possibility of a cable company trying to rise up as the fourth major mobile operator, but if Amazon can pass regulatory scrutiny, maybe Prime will cover one more thing pretty soon.

Stocks to Watch: Atlantic Capital Bancshares, Inc. (ACBI) and Westwood Holdings Group, Inc. (WHG) in the spotlight

by

The price of Atlantic Capital Bancshares, Inc. (NASDAQ:ACBI) went up by $0.15 now trading at $17.3. Their shares witnessed a 19.81% increase from the 52-week low price of $14.44 they recorded on 2018-10-26. Even though it is still -24.86% behind the $21.6 high touched on 2018-06-07. The last few days have been rough for the stock, as its price has decreased by -1.03% during the week. It has also performed poorly over the past three months, as it lost around -9.71% while it has so far retreated around -17.62% during the course of a year. The stock of ACBI recorded 5.68% uptrend from the beginning of this year till date. The 12-month potential price target for Atlantic Capital Bancshares, Inc. is set at $19.8. This target means that the stock has an upside potential to increase by 14.45% from the current trading price.

12 institutions entered new Atlantic Capital Bancshares, Inc. (NASDAQ:ACBI) positions, 50 added to their existing positions in these shares, 51 lowered their positions, and 16 exited their positions entirely.

Atlantic Capital Bancshares, Inc. (ACBI) trade volume has increased by 8.11% as around 120,772 shares were sold when compared with its 50-day average volume of traded shares which is 111,708. At the moment, ACBI is witnessing a downtrend, as it is trading -0.64% below its 20-day SMA, -2.72% below its 50-day SMA, and -1.72% below its 200-day SMA. The company runs an ROE of roughly 9%, with financial analysts predicting that their earnings per share growth will be around 11.8% per annum for the next five year. This will be compared to the 23.1% increase witnessed over the past five years.

The first technical resistance point for Atlantic Capital Bancshares, Inc. (NASDAQ:ACBI) will likely come at $17.45, marking a 0.86% premium to the current level. The second resistance point is at $17.61, about 1.76% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $16.77, the lower end of the range. ACBI’s 14-day MACD is -0.16 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 45.38, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 17.57 percent, which is low when compared to that of the 50-day’s 25.27 percent.

The shares of Westwood Holdings Group, Inc. (NYSE:WHG) has increased by 0.62%, and now trading at $30.73 on the Wall Street in the intra-day deal, with their shares traded now around 92,595. This is a rise of 38,609 shares over the average 53,986 shares that were traded daily over the last three months. The stock that is trading at $30.73 went higher by 3.99% from its 52-week low of $29.55 that it attained back on 2019-05-16. The stock recorded a 52-week high of $61.92 nearly 324 days ago on 2018-07-10.

WHG stock hasn’t performed well over the past 30 days, as it lost -6.23% while its price plunged by -9.62% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 1.69% over the last week. The stock’s 12-month potential target price is now at $0.

Westwood Holdings Group, Inc. (NYSE:WHG) has been utilizing an ROE that is roughly 11.9%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the 6.3% raise that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 0.85% above its 20-day SMA, -9.07% below its 50-day SMA, and -25.16% below its 200-day SMA. In percentage terms, the aggregate Westwood Holdings Group, Inc. shares held by institutional investors is 68%. 13 institutions jumped in to acquire Westwood Holdings Group, Inc. (WHG) fresh stake, 47 added to their current holdings in these shares, 35 lowered their positions, and 3 left no stake in the company.

The stock’s 9-day MACD is 0.33 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 48.99, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 16.72 percent, which is less when compared to that of the 50-day’s 34.23 percent. On the daily chart, we see that the stock could reach the first level of resistance at $30.99, sporting a 0.84% premium to the current level. The next resistance point is at $31.25, representing nearly 1.66% premium to the current market price of Westwood Holdings Group, Inc. (WHG). On the other hand, failure to breach the immediate hurdles can drag it down to $30.01, the lower end of the range.

Stocks to Watch: Eyes on Globalscape, Inc. (GSB), Kelso Technologies Inc. (KIQ)

by

The price of GlobalSCAPE, Inc. (NYSE:GSB) went up by $0.23 now trading at $8.93. The last few days have been good for the stock, as its price has grew by 3.96% during the week. It has also performed better over the past three months, as it added around 111.27% while it has so far climbed around 151.05% during the course of a year. The stock of GSB recorded 111.27% uptrend from the beginning of this year till date. The 12-month potential price target for GlobalSCAPE, Inc. is set at $0. This target means that the stock has an upside potential to increase by -100% from the current trading price.

5 institutions entered new GlobalSCAPE, Inc. (NYSE:GSB) positions, 20 added to their existing positions in these shares, 9 lowered their positions, and 3 exited their positions entirely.

GlobalSCAPE, Inc. (GSB) trade volume has increased by 142.78% as around 198,533 shares were sold when compared with its 50-day average volume of traded shares which is 81,776. At the moment, GSB is witnessing a uptrend, as it is trading 8.8% above its 20-day SMA, 23.13% above its 50-day SMA, and 81.56% above its 200-day SMA. The company runs an ROE of roughly 33.4%, with financial analysts predicting that their earnings per share growth will be around 0% per annum for the next five year. This will be compared to the -2.9% decrease witnessed over the past five years.

The first technical resistance point for GlobalSCAPE, Inc. (NYSE:GSB) will likely come at $9.04, marking a 1.22% premium to the current level. The second resistance point is at $9.16, about 2.51% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $8.48, the lower end of the range. GSB’s 14-day MACD is 0.13 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 67.71, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 36.01 percent, which is low when compared to that of the 50-day’s 39.77 percent.

The shares of Kelso Technologies Inc. (NYSE:KIQ) has increased by 1.36%, and now trading at $1.49 on the Wall Street in the intra-day deal, with their shares traded now around 85,965. This is a decline of -37,327 shares over the average 123,292 shares that were traded daily over the last three months. The stock that is trading at $1.49 went higher by 313.89% from its 52-week low of $0.36 that it attained back on 2018-10-29. The stock recorded a 52-week high of $1.66 nearly 9 days ago on 2019-05-21.

KIQ stock has performed well over the past 30 days, as it added 33.04% while its price climbed by 244.03% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -5.7% over the last week. The stock’s 12-month potential target price is now at $0.

Kelso Technologies Inc. (NYSE:KIQ) has been utilizing an ROE that is roughly 0%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the 0% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 12.42% above its 20-day SMA, 40.63% above its 50-day SMA, and 131.98% above its 200-day SMA. In percentage terms, the aggregate Kelso Technologies Inc. shares held by institutional investors is 0%. 1 institutions jumped in to acquire Kelso Technologies Inc. (KIQ) fresh stake, 4 added to their current holdings in these shares, 6 lowered their positions, and 1 left no stake in the company.

The stock’s 9-day MACD is -0.02 and this negative figure indicates a downward trading trend. The company’s 9-day RSI score is 64, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 69.83 percent, which is less when compared to that of the 50-day’s 75.34 percent. On the daily chart, we see that the stock could reach the first level of resistance at $1.53, sporting a 2.61% premium to the current level. The next resistance point is at $1.58, representing nearly 5.7% premium to the current market price of Kelso Technologies Inc. (KIQ). On the other hand, failure to breach the immediate hurdles can drag it down to $1.32, the lower end of the range.

Stocks to Watch: Eyes on Ampio Pharmaceuticals, Inc. (AMPE), Alnylam Pharmaceuticals, Inc. (ALNY)

by

The price of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) went up by $0.01 now trading at $0.52. Their shares witnessed a 48.57% increase from the 52-week low price of $0.35 they recorded on 2018-08-09. Even though it is still -515.38% behind the $3.2 high touched on 2018-07-27. The last few days have been rough for the stock, as its price has decreased by -5.44% during the week. It has also performed poorly over the past three months, as it lost around -16.28% while it has so far retreated around -74.63% during the course of a year. The stock of AMPE recorded 31.71% uptrend from the beginning of this year till date. The 12-month potential price target for Ampio Pharmaceuticals, Inc. is set at $14. This target means that the stock has an upside potential to increase by 2592.31% from the current trading price.

5 institutions entered new Ampio Pharmaceuticals, Inc. (NYSE:AMPE) positions, 22 added to their existing positions in these shares, 26 lowered their positions, and 11 exited their positions entirely.

Ampio Pharmaceuticals, Inc. (AMPE) trade volume has increased by 15.57% as around 468,803 shares were sold when compared with its 50-day average volume of traded shares which is 405,648. At the moment, AMPE is witnessing a downtrend, as it is trading -3.46% below its 20-day SMA, -5.21% below its 50-day SMA, and -3.79% below its 200-day SMA. The company runs an ROE of roughly 0%, with financial analysts predicting that their earnings per share growth will be around 0% per annum for the next five year. This will be compared to the 22.3% increase witnessed over the past five years.

The first technical resistance point for Ampio Pharmaceuticals, Inc. (NYSE:AMPE) will likely come at $0.54, marking a 3.7% premium to the current level. The second resistance point is at $0.56, about 7.14% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $0.48, the lower end of the range. AMPE’s 14-day MACD is -0.01 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 45.87, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 60.3 percent, which is high when compared to that of the 50-day’s 57 percent.

The shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has decreased by -0.73%, and now trading at $67.63 on the Wall Street in the intra-day deal, with their shares traded now around 738,643. This is a decline of -302,783 shares over the average 1,041,426 shares that were traded daily over the last three months. The stock that is trading at $67.63 went higher by 12.21% from its 52-week low of $60.27 that it attained back on 2018-12-24. The stock recorded a 52-week high of $124.21 nearly 272 days ago on 2018-08-31.

ALNY stock hasn’t performed well over the past 30 days, as it lost -23.61% while its price plunged by -7.24% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -0.35% over the last week. The stock’s 12-month potential target price is now at $125.22. This means that the stock price might likely increase by 85.15% from its current trading price. 14 out of 17 Wall Street analysts which represents 82.35% rated the stock as a buy while the remaining 17.65% rated it as a hold, with 0% of analysts rating it as a sell.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has been utilizing an ROE that is roughly -53.9%, with stock analysts predicting that the company’s EPS for the next five years will go up by 46.09% per year, following the -39.2% drop that was witnessed during the past five years. The stock at the moment is on a downtrend, trading -5.94% below its 20-day SMA, -17.42% below its 50-day SMA, and -19.34% below its 200-day SMA. In percentage terms, the aggregate Alnylam Pharmaceuticals, Inc. shares held by institutional investors is 92.3%. 36 institutions jumped in to acquire Alnylam Pharmaceuticals, Inc. (ALNY) fresh stake, 144 added to their current holdings in these shares, 117 lowered their positions, and 31 left no stake in the company.

The stock’s 9-day MACD is 0.41 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 34.1, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 29.78 percent, which is less when compared to that of the 50-day’s 44.08 percent. On the daily chart, we see that the stock could reach the first level of resistance at $68.62, sporting a 1.44% premium to the current level. The next resistance point is at $69.62, representing nearly 2.86% premium to the current market price of Alnylam Pharmaceuticals, Inc. (ALNY). On the other hand, failure to breach the immediate hurdles can drag it down to $65.8, the lower end of the range.

Stocks to Watch: Eyes on Trueblue, Inc. (TBI), Luna Innovations Incorporated (LUNA)

by

The price of TrueBlue, Inc. (NYSE:TBI) went down by $-0.1 now trading at $21.94. Their shares witnessed a 6.71% increase from the 52-week low price of $20.56 they recorded on 2018-12-26. Even though it is still -36.05% behind the $29.85 high touched on 2018-08-21. The last few days have been rough for the stock, as its price has decreased by -7.78% during the week. It has also performed poorly over the past three months, as it lost around -5.72% while it has so far retreated around -14.63% during the course of a year. The stock of TBI recorded -1.39% downtrend from the beginning of this year till date. The 12-month potential price target for TrueBlue, Inc. is set at $25.67. This target means that the stock has an upside potential to increase by 17% from the current trading price.

19 institutions entered new TrueBlue, Inc. (NYSE:TBI) positions, 87 added to their existing positions in these shares, 88 lowered their positions, and 14 exited their positions entirely.

TrueBlue, Inc. (TBI) trade volume has decreased by -14.83% as around 151,922 shares were sold when compared with its 50-day average volume of traded shares which is 178,374. At the moment, TBI is witnessing a downtrend, as it is trading -7.51% below its 20-day SMA, -8.55% below its 50-day SMA, and -10.54% below its 200-day SMA. The company runs an ROE of roughly 11.2%, with financial analysts predicting that their earnings per share growth will be around 10% per annum for the next five year. This will be compared to the 8% increase witnessed over the past five years.

The first technical resistance point for TrueBlue, Inc. (NYSE:TBI) will likely come at $22.08, marking a 0.63% premium to the current level. The second resistance point is at $22.23, about 1.3% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $21.45, the lower end of the range. TBI’s 14-day MACD is -1.1 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 29.94, which shows that its stock has been oversold. The 20-day historical volatility for the stock stands at 24.67 percent, which is low when compared to that of the 50-day’s 26.3 percent.

The shares of Luna Innovations Incorporated (NASDAQ:LUNA) has increased by 0.48%, and now trading at $4.18 on the Wall Street in the intra-day deal, with their shares traded now around 62,763. This is a decline of -44,411 shares over the average 107,174 shares that were traded daily over the last three months. The stock that is trading at $4.18 went higher by 55.97% from its 52-week low of $2.68 that it attained back on 2018-12-24. The stock recorded a 52-week high of $4.73 nearly 21 days ago on 2019-05-09.

LUNA stock hasn’t performed well over the past 30 days, as it lost -2.34% while its price climbed by 24.78% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -4.57% over the last week. The stock’s 12-month potential target price is now at $4.92. This means that the stock price might likely increase by 17.7% from its current trading price. 2 out of 3 Wall Street analysts which represents 66.67% rated the stock as a buy while the remaining 33.33% rated it as a hold, with 0% of analysts rating it as a sell.

Luna Innovations Incorporated (NASDAQ:LUNA) has been utilizing an ROE that is roughly 0%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the 15.7% raise that was witnessed during the past five years. The stock at the moment is on a downtrend, trading -5.65% below its 20-day SMA, -3.66% below its 50-day SMA, and 15.27% above its 200-day SMA. In percentage terms, the aggregate Luna Innovations Incorporated shares held by institutional investors is 30.2%. 8 institutions jumped in to acquire Luna Innovations Incorporated (LUNA) fresh stake, 16 added to their current holdings in these shares, 15 lowered their positions, and 3 left no stake in the company.

The stock’s 9-day MACD is -0.12 and this negative figure indicates a downward trading trend. The company’s 9-day RSI score is 32.94, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 35.85 percent, which is less when compared to that of the 50-day’s 36.01 percent. On the daily chart, we see that the stock could reach the first level of resistance at $4.27, sporting a 2.11% premium to the current level. The next resistance point is at $4.36, representing nearly 4.13% premium to the current market price of Luna Innovations Incorporated (LUNA). On the other hand, failure to breach the immediate hurdles can drag it down to $4, the lower end of the range.